DGAP-Adhoc

MOLOGEN AG: Verlustanzeige nach §92 Absatz 1 Aktiengesetz

MOLOGEN AG / Key word(s): Preliminary Results/Legal Matter

11.07.2016 17:20

Disclosure of an inside information according to Article 17 MAR,
transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Ad-hoc notification according to § 15 WpHG

MOLOGEN AG: Report of loss pursuant to section 92 para 1 of the German
Stock Corporation Act

Berlin, July 11, 2016. Pursuant to Section 92 Para. 1 of the German Stock
Corporation Act (AktG), the Executive Management Board of MOLOGEN AG (ISIN
DE0006637200/WKN 663720) indicates that the Company's provisional
registered share capital is down to just EUR10,681,859.09 as of June 30,
2016 dated July 11, 2016 as a result of losses incurred. This means that
half the Company's share capital of EUR22,631,501.00 has been wiped out by
losses. The losses mostly result from the Company's ordinary activities as
a research-based biotechnology company which is still developing and
without revenues of its own.

In the invitation to the Annual General Meeting which takes place on August
11, published on July 5, 2016 in the German Federal Gazette
(Bundesanzeiger), the Executive Management Board has already announced
under item 2 of the Agenda that a loss amounting to half the Company's
share capital was likely by the day of the Annual General Meeting at the
latest. The Executive Management Board will indeed report an actual loss
amounting to half the share capital at the Annual General Meeting and
discuss this together with a funding proposal. The Company's unaudited
interim results to June 30, 2016 will be submitted to the Annual General
Meeting. They will also be made available on the Company's website at
http://www.mologen.com/en/investor-relations-press/annual-general-
meeting.html and will also be made available for shareholder inspection at
the Annual General Meeting.

- End of the ad-hoc notification -

DISCLAIMER

This announcement does not constitute an offer to buy shares or other
securities of MOLOGEN AG and does not replace the prospectus. Investment
decisions with respect to the shares or other securities of MOLOGEN AG
shall only take place on the basis of the prospectus which will be
available after the approval by the German Financial Supervisory Authority
(BaFin) free of charge at MOLOGEN AG.
This announcement does not contain or constitute an offer of, or the
solicitation of an offer to buy or subscribe for, securities to any person